Phibro Animal Health Corporation is a drug manufacturers - specialty & generic business based in the US. Phibro Animal Health Corporation shares (PAHC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.39 – a decrease of 6.06% over the previous week. Phibro Animal Health Corporation employs 1,940 staff and has a trailing 12-month revenue of around $1 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $23.39 |
|---|---|
| 52-week range | $9.29 - $25.98 |
| 50-day moving average | $22.68 |
| 200-day moving average | $17.50 |
| Wall St. target price | $18.40 |
| PE ratio | 59.2857 |
| Dividend yield | $0.48 (1.9%) |
| Earnings per share (TTM) | $0.42 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $23.75 from 2024-11-19
| 1 week (2024-11-14) | -4.62% |
|---|---|
| 1 month (2024-10-21) | 0.42% |
| 3 months (2024-08-21) | 28.66% |
| 6 months (2024-05-21) | 29.29% |
| 1 year (2023-11-21) | 131.93% |
|---|---|
| 2 years (2022-11-21) | 104.91% |
| 3 years (2021-11-19) | 19.82% |
| 5 years (2019-11-21) | 15.86% |
Valuing Phibro Animal Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phibro Animal Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Phibro Animal Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 59x. In other words, Phibro Animal Health Corporation shares trade at around 59x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Phibro Animal Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6618. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Phibro Animal Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Phibro Animal Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $116.1 million.
The EBITDA is a measure of a Phibro Animal Health Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 8.11% |
| Gross profit TTM | $298.2 million |
| Return on assets TTM | 5.26% |
| Return on equity TTM | 6.55% |
| Profit margin | 1.66% |
| Book value | $6.38 |
| Market Capitalization | $1 billion |
TTM: trailing 12 months
Dividend payout ratio: 34.29% of net profits
Recently Phibro Animal Health Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Phibro Animal Health Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Phibro Animal Health Corporation's case, that would currently equate to about $0.48 per share.
While Phibro Animal Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Phibro Animal Health Corporation may be investing much of the rest of its net profits in future growth.
Phibro Animal Health Corporation's most recent dividend payout was on 24 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 26 November 2024 (the "ex-dividend date").
Over the last 12 months, Phibro Animal Health Corporation's shares have ranged in value from as little as $9.2851 up to $25.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phibro Animal Health Corporation's is 0.51. This would suggest that Phibro Animal Health Corporation's shares are less volatile than average (for this exchange).
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.